 | Up a level |
Schindewolf, M.; Brüggenjürgen, B.; Ay, C.; Hainaut, P.; Hoffmann, U.; Gaine, S.; Coppens, M.; Jiménez, D.; Levy, P.; López Bastida, J.; Vicaut, E.; Bramlage, P.; Agnelli, G.; Cohen, A.T. (11 August 2020). ETNA-VTE Europe: The Effect of Body Mass Index on 12-Month Outcomes in VTE Patients with Edoxaban. Research and practice in thrombosis and haemostasis, 4(S1), pp. 1229-1230. Wiley
Coppens, M.; Cohen, A.T.; Ay, C.; Hainaut, P.; Hoffmann, U.; Gaine, S.; Jiménez, D.; Schindewolf, M.; Brüggenjürgen, B.; Levy, P.; López Bastida, J.; Vicaut, E.; Bramlage, P.; Agnelli, G. (July 2020). Association Between Index VTE Event and 12-Months Outcomes for Patients in Routine Clinical Practice Enrolled in the ETNA-VTE-Europe Registry. In: ISTH 2020 Virtual Congress of the International Society on Thrombosis and Haemostasis. July 12 - 14, 2020.
